🔎 Trials Near Me

Nyumbani › Osteosarcoma › Massachusetts › Boston

Majaribio ya kliniki ya Osteosarcoma katika Boston, MA

Masomo 9 ya Osteosarcoma yanatafuta washiriki katika vituo vya Boston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

InaajiriHatua 2
  • Dana-Farber Cancer Institute, Boston
Umri 12 hadi 39 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT04616560

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

InaajiriHatua 3
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Hadi umri 50 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

InaajiriHatua 1/2
  • Dana-Farber Cancer Institute, Boston
12 Months – 30 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

InaajiriHatua 1/2
  • Dana Farber Cancer Institute, Boston
Umri 2 hadi 21 · Jinsia zote · Imesasishwa 11 Ago 2026 · NCT05642455

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

InaajiriHatua 1/2
  • Dana Farber Cancer Institute, Boston
Hadi umri 30 · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT06239272

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

InaajiriUtafiti wa uchunguzi
  • Dana-Farber Cancer Institute, Boston
Umri wote · Jinsia zote · Imesasishwa 18 Mei 2026 · NCT01790152

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

InaajiriHatua 1/2
  • Dana Farber Cancer Institute, Boston
Umri 12 na zaidi · Jinsia zote · Imesasishwa 1 Mei 2026 · NCT07357519

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

InaajiriHatua 2
  • Dana-Farber Cancer Institute, Boston
Umri 12 na zaidi · Jinsia zote · Imesasishwa 17 Apr 2026 · NCT05019703

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

InaajiriHatua 1/2
  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Umri 12 hadi 49 · Jinsia zote · Imesasishwa 19 Feb 2026 · NCT06709495

Majaribio ya Osteosarcoma katika miji mingine

Masomo mengine katika Boston

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.